NHF’s QMS is ISO – 9001:2015 Certified · Government of Jamaica

An agency of the Ministry of Health & Wellness

NHF Adds New Drug for Benign Prostatic Hyperplasia (BPH)

NHF Adds New Drug for Benign Prostatic Hyperplasia (BPH) and Hypertension

 

National Health Fund (NHF) cardholders are to benefit from the addition of new drugs for the treatment of Benign Prostatic Hyperplasia (BPH) and Hypertension.

New, for the treatment of Benign Prostatic Hyperplasia, is Duodart capsules with the active ingredients Dutasteride and Tamsulosin, with a NHF subsidy of $130.80 per 0.5mg tablet.

In addition, Cozaar XQ tablets with the combination of the active ingredients Losartan and Amlodipine for the treatment of Hypertension has been added.  The NHF offers a subsidy of $33.61 for a 50 mg tablet and $58.37 for a 100 mg tablet.

These changes became effective January 28, 2015.

A complete drug list and subsidies paid by the NHF are available from NHF participating Pharmacies, the NHF website or by calling NHF (1-888-NHF-CARE).

For further information please contact:
Shermaine Robotham, Public Information Manager (Acting)
Jillian Green, Media Coordinator
Telephone: 906-1106

An agency of the Ministry of Health & Wellness
NHF’s QMS is ISO – 9001:2015 Certified

National Health Fund The Towers,
6th Floor 25 Dominica Drive,
Kingston 5

(876) 906-1106 / (876) 906-4381

1-888-DIAL-NHF (342-5643)

[email protected]

National Health Fund © 2024. All Rights Reserved.